Navigation Links
Renowned Chinese Herbal Medicine Development Specialist Joins China Health Resources
Date:2/13/2008

SUINING, China, Feb. 13 /Xinhua-PRNewswire/ -- China Health Resources Co., Ltd. (CHRI; OTC Bulletin Board: CHRI) announced that Jia Minru, famous professor of the Chinese Medicine University and authoritative Chinese physician, joined CHRI recently to be responsible for deep development, high-tech development and systematic research of deep processed products of Chuan DAR GAP.

The joining of Jia Minru will certainly strengthen the research and development force of CHRI. With the technological advantage of CHRI, Jia will take part in realizing the commercial development with more advanced technology and more commercial value for Suining Chuan DAR and its processed products.

Jia has more than 40 years of research experience in medicine and herb resource development. He was the Advisor of the Chinese Medicine Academy, the Dean of Chinese Medicine University, the deputy dean of Chinese Medicine Association, Director of Chinese Medicine and Herb Committee, and a Member of Sichuan New Medicine Assessment Center.

About the Company

China Health Resources Co., Ltd. (CHRI) was incorporated on April 24, 2001. It is one of China's leading industrialized agricultural corporations. CHRI focuses on the production and further processing of Dahurian Angelica Root (DAR), a herb that is widely used in China, and considered to be an important ingredient in Chinese traditional medicine. CHRI's business plan includes distributing DAR and its processed products to exploit a large market in the areas of treatment of pain, swelling and pustule. Good Agricultural Practice (GAP) is a national compulsory criterion for food and drug industries. The goal of GAP is to help agricultural product companies deal with the usual micro-organism harm so as to enhance safety of agricultural products. CHRI has accomplished GAP certification of Chuan DAR, making DAR products and related production technology of the Company part of the industry criteria.

Statements regarding financial matters in this press release other than historical facts are 'forward-looking statements' within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such proclamations about future expectations, including future revenues and earnings and all other forward-looking statements be subject to the safe harbors created thereby. CHRI depends on outside resources to maintain its continuation. Since these statements involve risks and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results.

For more information, please contact:

Office of CHRI

Tel: +86-825-239-1788

343 Suining Zhong Road, Suining, Sichuan, P.R. China

Website: http://www.chinahealthresource.com


'/>"/>
SOURCE China Health Resources Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cleveland Clinic Recruits World Renowned Heart Rhythm Specialist to Direct Electrophysiology
2. Childrens Hospital Boston Mourns the Death of Dr. Judah Folkman, World Renowned Researcher and Founder of the Field of Angiogenesis
3. HealthONE(R) Appoints Nationally Renowned Pediatric Cardiologist & Childhood Obesity Expert as First Chief Medical Officer for the Rocky Mountain Hospital for Children(SM)
4. BREATHE Lung Cancer Conference, Nov. 30, Attracts World Renowned Physicians and Speakers
5. World-Renowned Therapist Joins The Center for Children and Families In Its Work With the Nations Poorest Families
6. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
7. China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection
8. Linkwell Chairman & CEO Addresses the Association of Chinese Nosocomial Infections Professional Committee
9. What are the essential characteristics of serum PG in Chinese?
10. Rh-Apo2L Named as One of Chinas High-Tech Transforming Products by Chinese Government
11. All-State Properties, L.P. Announces Termination of Reverse Merger With Chinese Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 2017 , ... Attorney Robert “RC” Pate , founder of The Law ... Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric cancers. ... the effect of the critical funding gap for research into pediatric cancer research. From ...
(Date:1/19/2017)... ... 2017 , ... The CHP suggests that California drivers can avoid hydroplaning as ... and increasing the space between themselves and other vehicles, according to a January 3 ... R. Hassanlou notes that, rain or shine, drivers should always incorporate safe driving practices ...
(Date:1/19/2017)... ... January 19, 2017 , ... The 21st Century Cures Act’s Impact ... Webinar**, Jan. 26, 2016 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          ... Act in order to thrive this year? , The passage of the act means ...
(Date:1/19/2017)... ... January 19, 2017 , ... Infinity® Massage Chairs announced today ... implement new sales and marketing strategies. Grover comes with a total of 15 years ... a half years as Executive Vice President of Direct Sales at Traeger® Wood Pellet ...
(Date:1/19/2017)... ... January 19, 2017 , ... Fillers are known for ... people know that popular cosmetic fillers can enhance earlobes and rejuvenate ... director of the MilfordMD Cosmetic Dermatology Surgery & Laser Center, in Milford, Penn. ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... Jan. 18, 2017  Kratom leaves, from a ... are often used to prepare tea-like beverages and ... million Americans annually to increase alertness, enhance well-being ... for minor aches and pains. PinneyAssociates, review of ... to assist FDA and DEA in determining the ...
(Date:1/18/2017)... , Jan. 18, 2017  Dermata Therapeutics, LLC, ... to treat a variety of dermatological diseases, announces ... DMT210, in a Phase 2 acne rosacea study. ... downregulate the proinflammatory cytokines in the skin responsible ... rosacea. This clinical trial, DMT210-003, ...
(Date:1/18/2017)... , Suiza, 18 de enero de 2017  Hoy, ... lanzaron Access Accelerated, una iniciativa global para avanzar el ... y atención en países de renta baja y baja-media ... alcanzado un punto de crisis, particularmente en países de ... 80 por ciento de las muertes relacionadas con NCD. ...
Breaking Medicine Technology: